GCANRx Announces Uplisting to New Market Tier

BALTIMORE, June 30, 2025 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products is pleased to announce that its application to the OTCID Basic Market has been officially approved by OTC Markets Group. The upgrade will take effect upon the market's launch on July 1, 2025 and marks a significant milestone in GCAN’s ongoing efforts to strengthen its presence in the capital markets.